These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22072099

  • 1. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
    Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    Cancer; 2012 Jul 01; 118(13):3302-10. PubMed ID: 22072099
    [Abstract] [Full Text] [Related]

  • 2. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus.
    Wu J, Huang WJ, Wang HY, Wang YF, Peng BG, Zhou Q.
    Med Oncol; 2015 Mar 01; 32(3):65. PubMed ID: 25691293
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma.
    Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    Int J Clin Oncol; 2011 Jun 01; 16(3):221-9. PubMed ID: 21132451
    [Abstract] [Full Text] [Related]

  • 4. Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b.
    Mawatari H, Kirikoshi H, Yoneda M, Higurashi T, Fujita K, Saito S, Inamori M, Takahashi H, Abe Y, Kubota K, Nakajima A.
    Hepatogastroenterology; 2008 Jun 01; 55(86-87):1776-7. PubMed ID: 19102391
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
    Kasai K, Kooka Y, Suzuki Y, Suzuki A, Oikawa T, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Takikawa Y.
    Ann Surg Oncol; 2014 Oct 01; 21(11):3638-45. PubMed ID: 24817369
    [Abstract] [Full Text] [Related]

  • 6. Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus.
    Hirooka M, Koizumi Y, Kisaka Y, Abe M, Murakami H, Matsuura B, Hiasa Y, Onji M.
    AJR Am J Roentgenol; 2010 Feb 01; 194(2):W221-6. PubMed ID: 20093578
    [Abstract] [Full Text] [Related]

  • 7. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
    Uka K, Aikata H, Takaki S, Miki D, Jeong SC, Hiramatsu A, Kodama H, Shirakawa H, Kawakami Y, Takahashi S, Toyota N, Ito K, Chayama K.
    Liver Int; 2007 Nov 01; 27(9):1209-16. PubMed ID: 17919232
    [Abstract] [Full Text] [Related]

  • 8. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M, Kobayashi Y, Urawa N, Yamamoto M, Mifuji R, Araki J, Tanaka H, Horiike S, Itani T, Furjita N, Konishi M, Iwasa M, Kaito M, Adachi Y.
    Hepatogastroenterology; 2007 Mar 01; 54(74):518-21. PubMed ID: 17523311
    [Abstract] [Full Text] [Related]

  • 9. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
    Okita K, Yamasaki T, Hamabe S, Saeki I, Harima Y, Terai S, Sakaida I.
    Hepatogastroenterology; 2012 Mar 01; 59(114):533-7. PubMed ID: 22353519
    [Abstract] [Full Text] [Related]

  • 10. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Eun JR, Lee HJ, Moon HJ, Kim TN, Kim JW, Chang JC.
    Scand J Gastroenterol; 2009 Mar 01; 44(12):1477-86. PubMed ID: 19958061
    [Abstract] [Full Text] [Related]

  • 11. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, Sumie S, Yano Y, Okuda K, Sata M.
    Cancer; 2002 Aug 01; 95(3):588-95. PubMed ID: 12209752
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
    Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S, Tateishi R, Teratani T, Shiina S, Omata M.
    Cancer; 2006 May 01; 106(9):1990-7. PubMed ID: 16565970
    [Abstract] [Full Text] [Related]

  • 13. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases.
    Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K.
    J Gastroenterol Hepatol; 2010 Jun 01; 25(6):1117-22. PubMed ID: 20074168
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.
    Uka K, Aikata H, Takaki S, Miki D, Kawaoka T, Jeong SC, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol; 2007 Oct 01; 42(10):845-53. PubMed ID: 17940838
    [Abstract] [Full Text] [Related]

  • 15. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.
    Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M.
    Cancer; 2002 Jan 15; 94(2):435-42. PubMed ID: 11900229
    [Abstract] [Full Text] [Related]

  • 16. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Ota H, Nakamura M, Wada H, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshit K, Nakamori S, Monden M.
    Hepatogastroenterology; 2007 Jan 15; 54(73):172-9. PubMed ID: 17419255
    [Abstract] [Full Text] [Related]

  • 17. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY, Cheong JY, Cho SW, Sim SJ, Kim JS, Choi SJ, Choi JW, Kwon HC, Lee KM, Kim JK, Won JH, Yoo BM, Lee KJ, Hahm KB, Kim JH.
    Korean J Hepatol; 2006 Mar 15; 12(1):65-73. PubMed ID: 16565607
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis.
    Kaneko S, Urabe T, Kobayashi K.
    Oncology; 2002 Mar 15; 62 Suppl 1():69-73. PubMed ID: 11868789
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
    Nagano H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Tomimaru Y, Osuga K, Umeshita K, Doki Y, Mori M.
    Oncology; 2011 Mar 15; 80(1-2):63-9. PubMed ID: 21659784
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
    Nagamatsu H, Sumie S, Niizeki T, Tajiri N, Iwamoto H, Aino H, Nakano M, Shimose S, Satani M, Okamura S, Kuromatsu R, Matsugaki S, Kurogi J, Kajiwara M, Koga H, Torimura T.
    Cancer Chemother Pharmacol; 2016 Feb 15; 77(2):243-50. PubMed ID: 26754678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.